As reported by Loreth et al. [36], CD44 is expressed on the majority of CTCs obtained from patients with breast cancer, non-small cell lung cancer and melanoma with brain metastases while being much less expressed in the metastatic tissue. This evidence concerns the gene CD44 and breast carcinoma.